Regulatory 2025-01-30 | NOTICE OF EXTRAORDINARY GENERAL MEETING IN ASCELIA PHARMA AB PDF Report Presentation Webcast
Regulatory 2024-11-22 | Ascelia Pharma Resolves on Conversion of Series C Shares into Ordinary Shares for Delivery to Participants in Incentive Program PDF Report Presentation Webcast
Regulatory 2024-11-07 | Quarterly Report Q3: Successful Outcome from Rights Issue with SEK 105 Million Extends Runway Until Late 2025 PDF Report Presentation Webcast
Regulatory 2024-10-30 | Bulletin from the Extraordinary General Meeting in Ascelia Pharma AB on 30 October 2024 PDF Report Presentation Webcast
Regulatory 2024-10-04 | Notice of Extraordinary General Meeting in Ascelia Pharma AB PDF Report Presentation Webcast
Regulatory 2024-10-04 | Ascelia Pharma Announces Proposal for Election of Marianne Kock as New Member of the Board of Directors PDF Report Presentation Webcast
Regulatory 2024-09-13 | Ascelia Pharma Resolves on a Directed Issue of Convertibles of SEK 7.5 Million PDF Report Presentation Webcast
Regulatory 2024-09-05 | Ascelia Pharma Announces Final Outcome in Fully Subscribed SEK 105 Million Rights Issue PDF Report Presentation Webcast
Regulatory 2024-09-04 | Ascelia Pharma Announces Preliminary Outcome in Rights Issue PDF Report Presentation Webcast
Regulatory 2024-08-16 | Ascelia Pharma Announces Prospectus in Connection with Rights Issue PDF Report Presentation Webcast
Regulatory 2024-08-14 | Bulletin from the Extraordinary General Meeting in Ascelia Pharma AB on 14 August 2024 PDF Report Presentation Webcast
Regulatory 2024-08-09 | Ascelia Pharma Announces Final Terms of Rights Issue PDF Report Presentation Webcast
Regulatory 2024-07-10 | Notice of Extraordinary General Meeting in Ascelia Pharma AB PDF Report Presentation Webcast
Regulatory 2024-05-16 | Quarterly Report Q1: Primary Endpoint Met with Strong Headline Results in Orviglance Phase 3 Study PDF Report Presentation Webcast
Regulatory 2024-05-06 | Bulletin from the Annual General Meeting in Ascelia Pharma AB on 6 May 2024 PDF Report Presentation Webcast
Regulatory 2024-03-27 | Notice of Annual General Meeting in Ascelia Pharma AB PDF Report Presentation Webcast
Regulatory 2024-02-09 | Q4 and Full Year Report 2023: Strengthened Financial Position Ahead of SPARKLE Phase 3 Study Headline Results in May PDF Report Presentation Webcast
Regulatory 2024-01-24 | Nomination Committee Appointed for AGM 2024 in Ascelia Pharma AB PDF Report Presentation Webcast
